Intellectus Partners, LLC Relay Therapeutics, Inc. Transaction History

Intellectus Partners, LLC

$486 Million
Q3 2025

A detailed history of Intellectus Partners, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Intellectus Partners, LLC holds 56,425 shares of RLAY stock, worth $373,533. This represents 0.06% of its overall portfolio holdings.

Number of Shares

56,425

Previous 61,425 8.14%

Holding current value

$373,533

Previous $212,000 38.68%

% of portfolio

0.06%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$3.22 - $5.22 $16,100 - $26,100	-5,000 Reduced 8.14%	56,425 $294,000
Q4 2024 Feb 07, 2025	SELL	$4.12 - $6.8 $25,750 - $42,500	-6,250 Reduced 9.24%	61,425 $253,000
Q2 2024 Jul 18, 2024	SELL	$5.9 - $8.02 $9,351 - $12,711	-1,585 Reduced 2.29%	67,675 $441,000
Q1 2024 May 03, 2024	BUY	$7.5 - $12.07 $145,500 - $234,158	19,400 Added 38.91%	69,260 $574,000
Q4 2023 Feb 05, 2024	SELL	$6.01 - $11.48 $4,207 - $8,036	-700 Reduced 1.38%	49,860 $548,000

Q3 2023 Oct 25, 2023	BUY	$8.24 - $12.97 $16,480 - $25,940	2,000 Added 4.12%	50,560 $425,000
Q2 2023 Jul 31, 2023	BUY	$9.99 - $18.27 $216,533 - $396,002	21,675 Added 80.62%	48,560 $609,000
Q1 2023 May 04, 2023	SELL	$15.0 - $22.76 $28,500 - $43,244	-1,900 Reduced 6.6%	26,885 $442,000
Q4 2022 Feb 02, 2023	BUY	$14.16 - $24.02 $39,648 - $67,256	2,800 Added 10.78%	28,785 $430,000
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $31,170 - $54,113	1,725 Added 7.11%	25,985 $581,000
Q2 2022 Aug 12, 2022	BUY	$13.31 - $34.88 $23,824 - $62,435	1,790 Added 7.97%	24,260 $406,000
Q1 2022 May 16, 2022	SELL	$20.26 - $32.36 $74,962 - $119,732	-3,700 Reduced 14.14%	22,470 $673,000
Q4 2021 Feb 14, 2022	SELL	$26.0 - $37.03 $208,624 - $297,128	-8,024 Reduced 23.47%	26,170 $803,000
Q3 2021 Nov 16, 2021	BUY	$29.75 - $37.99 $4,462 - $5,698	150 Added 0.44%	34,194 $1.08 Million
Q2 2021 Aug 13, 2021	BUY	$27.5 - $38.19 $252,697 - $350,927	9,189 Added 36.97%	34,044 $1.25 Million
Q1 2021 May 17, 2021	BUY	$32.52 - $61.53 $491,214 - $929,410	15,105 Added 154.92%	24,855 $859,000
Q4 2020 Feb 18, 2021	BUY	$35.51 - $54.03 $313,517 - $477,030	8,829 Added 958.63%	9,750 $405,000
Q4 2020 Feb 12, 2021	BUY	$35.51 - $54.03 $32,704 - $49,761	921 New	921 $405,000

Others Institutions Holding RLAY

# of Institutions

215

Shares Held

168M

Call Options Held

714K

Put Options Held

14.9K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $796M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Relay Therapeutics, Inc. Transaction History